Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effervescent/buffered alendronate vs conventional alendronate in postmenopausal osteopenia
2020-005040-35Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alendronate in osteopenia (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Percent change in CTx from baseline to end of study. Started Dec 2020; status: completed.
02
Drugs
alendronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on 2020-005040-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005040-35.